# SOX-based CRT for Esophageal Cancer.

> **NCT03991104** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Zhejiang Provincial People's Hospital**

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** Oxaliplatin
- **DRUG:** S-1 capsule
- **RADIATION:** Intensity modulated radiotherapy (IMRT)

## Key facts

- **NCT ID:** NCT03991104
- **Lead sponsor:** Zhejiang Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-05-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No eligible patients enrolled. We have to withdraw the trial.
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03991104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03991104, "SOX-based CRT for Esophageal Cancer.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03991104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*